Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin ETFs See Outflows as Ether ETFs Takes Center Stage

Bitcoin ETFs See Outflows as Ether ETFs Takes Center Stage

DailycoinDailycoin2024/07/25 11:49
By:Dailycoin
  • Investors have been pulling out of Bitcoin ETFs
  • Ethereum ETFs have debuted successfully.
  • The competition between Bitcoin and Ethereum ETFs has begun.

The excitement surrounding Bitcoin ETFs appeared to be in full swing on Monday, with a significant $526.7 million influx of investment pouring into the burgeoning market, a clear sign that mainstream sentiment was finally returning. However, a plot twist emerged by Tuesday, throwing the party into disarray and leaving Bitcoin ETFs scrambling for attention.

Ether ETFs Drive Capital Shift Away from Bitcoin ETFs

While BlackRock’s iShares Bitcoin Trust (IBIT) continued to see inflows, the overall market witnessed a net outflow of $77.97 million, according to data from SoSoValues. This reversal could be attributed to the highly anticipated launch of several Ethereum ETFs, which dominated investor attention on their first day of trading.

Sponsored

Following the major inflows on Monday, IBIT remained the lone bright spot among Bitcoin ETFs on Tuesday. This highlights the fund’s continued appeal to investors seeking exposure to Bitcoin. However, broader market sentiment shifted, with significant outflows observed in other prominent funds.

Grayscale Bitcoin Trust (GBTC) experienced a net outflow of $27.31 million, while ARK Innovation ETF (ARKB), which holds some Bitcoin exposure, saw a loss of $52.29 million. Bitwise Bitcoin Strategy ETF (BITB) also faced a substantial outflow of $70.32 million.

Ether ETFs Land Well: $1B Traded on Day 1

The primary driver behind this shift in investor focus appears to be Tuesday’s much-awaited launch of several Ethereum ETFs. These new investment vehicles, offering direct exposure to Ethereum, the second-largest cryptocurrency, captured significant investor interest. The total trading volume of these Ethereum ETFs surpassed $1 billion on their first day.

This development underscores the dynamic nature of the cryptocurrency ETF market. While Bitcoin ETFs have established a strong presence, the emergence of new asset class options like Ethereum ETFs can significantly influence investor behavior. 

Sponsored

It’s important to note that outflows don’t necessarily indicate a decline in investor confidence in Bitcoin itself but rather a potential reallocation of capital within the cryptocurrency space. Recent events suggest a potential future where investors have a wider range of cryptocurrency exposure options through ETFs. 

On the Flipside

  • While there was a net outflow overall, BlackRock’s iShares Bitcoin Trust (IBIT) continued to see inflows.
  • Though Ethereum ETFs had a strong debut, it’s too early to say if this will be a lasting trend or a short-term move by investors.
  • The focus on Ethereum ETFs was most likely due to the novelty of their launch. Investor preference might return to Bitcoin ETFs after the initial excitement fades.

Why This Matters

Despite initial excitement for Bitcoin ETFs, the splashy launch of Ethereum ETFs and their $1 billion trading day has stolen some thunder. This capital shift suggests investor interest in diversifying beyond Bitcoin within the ETF structure, potentially leading to a future where Bitcoin ETFs hold steady appeal but compete with a growing range of altcoin options.

Experts are predicting how Ether ETFs will perform in the market. To learn more about what they foresee, read here:
Ether ETFs Approved for Trading! Here’s How Experts See Them Performing

BlackRock’s iShares Bitcoin Trust (IBIT) is leading spot Bitcoin ETF inflows. To learn more about IBIT dethroning Grayscale’s GBTC, read here:
BlackRock’s IBIT Leads Spot Bitcoin ETF Inflows with $526.7M

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23